雅各臣科研制药(02633)：委任承建商推进大埔创新园基建工程

智通财经

Apr 01

智通财经APP讯，雅各臣科研制药(02633)发布公告，于2026年4月1日，代表公司间接全资附属公司正美药品行事的顾问(区兆坚建筑及工程设计顾问有限公司)，签立接纳函以确认承建商(瑞安承建有限公司)就于大埔厂房提供特定基建发展及专项设施工程所提交的投标，合约总额为6.072亿港元。

于2025年，正美药品收购位于中国香港新界大埔大埔工业邨大喜街7号的专用制药设施大埔厂房。正美药品拟于该设施建立十条新智能制药生产线，涵盖无菌眼药水、固体剂型及口服液药物。

顾问透过公开招标程序，协助正美药品评估所提交的标书，并就提供该特定基建发展及专项设施工程对承建商提交的标书作出推荐建议。

集团持续致力推进其在专用药及智能制造领域的策略重点。在中国香港政府新型工业加速计划的支持下，大埔设施将成为该策略的基石。该设施采用AI及机械人驱动的无菌、固体及口服液剂型生产线，旨在支持高效优质的生产，同时应付本地及全球的医疗保健需求。

预期交易将为集团带来巨大裨益。在策略方面，此举巩固公司在制药业的领先地位，并符合香港成为先进工业枢纽的愿景。就创新而言，该设施利用先进技术及协作能力提升生产效率、品质及竞争力，支持集团的长远增长目标。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2624139655"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2624139655\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2624139655?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-04-01 20:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2624139655","market":"sh","top_or_hot":-1,"title":"雅各臣科研制药(02633)：委任承建商推进大埔创新园基建工程","media":"智通财经","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/02633\">雅各臣科研制药</a>(02633)发布公告，于2026年4月1日，代表公司间接全资附属公司正美药品行事的顾问(区兆坚建筑及工程设计顾问有限公司)，签立接纳函以确认承建商(瑞安承建有限公司)就于大埔厂房提供特定基建发展及专项设施工程所提交的投标，合约总额为6.072亿港元。</p><p>于2025年，正美药品收购位于中国香港新界大埔大埔工业邨大喜街7号的专用制药设施大埔厂房。正美药品拟于该设施建立十条新智能制药生产线，涵盖无菌眼药水、固体剂型及口服液药物。</p><p>顾问透过公开招标程序，协助正美药品评估所提交的标书，并就提供该特定基建发展及专项设施工程对承建商提交的标书作出推荐建议。</p><p>集团持续致力推进其在专用药及智能制造领域的策略重点。在中国香港政府新型工业加速计划的支持下，大埔设施将成为该策略的基石。该设施采用AI及机械人驱动的无菌、固体及口服液剂型生产线，旨在支持高效优质的生产，同时应付本地及全球的医疗保健需求。</p><p>预期交易将为集团带来巨大裨益。在策略方面，此举巩固公司在制药业的领先地位，并符合香港成为先进工业枢纽的愿景。就创新而言，该设施利用先进技术及协作能力提升生产效率、品质及竞争力，支持集团的长远增长目标。</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>雅各臣科研制药(02633)：委任承建商推进大埔创新园基建工程</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n雅各臣科研制药(02633)：委任承建商推进大埔创新园基建工程\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-01 20:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1424173.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，雅各臣科研制药(02633)发布公告，于2026年4月1日，代表公司间接全资附属公司正美药品行事的顾问(区兆坚建筑及工程设计顾问有限公司)，签立接纳函以确认承建商(瑞安承建有限公司)就于大埔厂房提供特定基建发展及专项设施工程所提交的投标，合约总额为6.072亿港元。于2025年，正美药品收购位于中国香港新界大埔大埔工业邨大喜街7号的专用制药设施大埔厂房。正美药品拟于该设施建立十条...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1424173.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02633","symbol_name":"雅各臣科研制药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1424173.html","article_id":"2624139655","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2624139655","pubTimestamp":1775044859,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，雅各臣科研制药 发布公告，于2026年4月1日，代表公司间接全资附属公司正美药品行事的顾问，签立接纳函以确认承建商就于大埔厂房提供特定基建发展及专项设施工程所提交的投标，合约总额为6.072亿港元。于2025年，正美药品收购位于中国香港新界大埔大埔工业邨大喜街7号的专用制药设施大埔厂房。在策略方面，此举巩固公司在制药业的领先地位，并符合香港成为先进工业枢纽的愿景。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"165525":"基建工程","399995":"基建工程","02633":"雅各臣科研制药","BK1191":"制药"},"translate_title":"Jacobson Scientific & Pharmaceuticals (02633): Appointment of Contractor to Promote Tai Po Innovation Park Infrastructure","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"165525":1.5,"399995":1.5,"02633":1.5},"content_text":"智通财经APP讯，雅各臣科研制药(02633)发布公告，于2026年4月1日，代表公司间接全资附属公司正美药品行事的顾问(区兆坚建筑及工程设计顾问有限公司)，签立接纳函以确认承建商(瑞安承建有限公司)就于大埔厂房提供特定基建发展及专项设施工程所提交的投标，合约总额为6.072亿港元。于2025年，正美药品收购位于中国香港新界大埔大埔工业邨大喜街7号的专用制药设施大埔厂房。正美药品拟于该设施建立十条新智能制药生产线，涵盖无菌眼药水、固体剂型及口服液药物。顾问透过公开招标程序，协助正美药品评估所提交的标书，并就提供该特定基建发展及专项设施工程对承建商提交的标书作出推荐建议。集团持续致力推进其在专用药及智能制造领域的策略重点。在中国香港政府新型工业加速计划的支持下，大埔设施将成为该策略的基石。该设施采用AI及机械人驱动的无菌、固体及口服液剂型生产线，旨在支持高效优质的生产，同时应付本地及全球的医疗保健需求。预期交易将为集团带来巨大裨益。在策略方面，此举巩固公司在制药业的领先地位，并符合香港成为先进工业枢纽的愿景。就创新而言，该设施利用先进技术及协作能力提升生产效率、品质及竞争力，支持集团的长远增长目标。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}